Indefinite Delivery Contract VA257C0211TO0017

The National Institutes of Health (NIH) Clinical Center has awarded a single-award, indefinite delivery contract to Quva Pharma, Inc. to provide non-patient-specific sterile compounded pharmaceutical products for patients at the NIH Clinical Center on an as-needed basis. The contract has a ceiling value of $250,000 and a period of performance ending on September 30, 2025. Quva Pharma, a specialized pharmaceutical company that operates as a 503B outsourcing facility, will supply sterile...

This is a single award Indefinite Delivery Contract issued by the Department of the Army Medical Command to Complete Pharmacy And Medical Solutions, LLC, a for-profit limited liability company. The contract is for the supply of compounded pharmaceutical products, with a period of performance ending on September 30, 2022 and a potential total value of $1,342,433.30. The specific task order provided is for the supply of ROPIVACAINE PF 0.2% 100 ML CADD, with a period of performance ending on...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery indefinite quantity contract with a potential value of $2.2 million to Sierra Radiopharmacy LLC of Reno, Nevada. The contract provides for the delivery of radiopharmaceuticals to support nuclear medicine procedures at VA medical facilities in Reno. Three firm fixed price delivery orders have been issued against the contract to date, valued at $751,665, $655,070,...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 has awarded Revance Therapeutics, Inc., a for-profit organization, an Interim Agreement under Federal Supply Schedule (FSS) 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. This is a Multiple Award contract with a potential value of $25,000.00 and a period of performance running through May 14, 2024. The contract aims to procure pharmaceutical products and related services....

This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Pine Pharmaceuticals LLC, a limited liability company located in Tonawanda, New York. The contract is for the provision of 503B compounding pharmaceutical services, with a total ceiling value of $136,915. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding, repackaging, and the production of...

The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...

This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals, Inc. to supply gabapentin capsules in various package sizes to meet the estimated annual needs of the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite delivery contract has a total ceiling value of $54,110,891.35 and a base period of performance from November 11, 2023 through November...

This Federal Supply Schedule contract awards Pacira Pharmaceuticals, Inc. as the prime contractor to provide the Department of Veterans Affairs (VA) with a range of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contract has a total potential value of $93,582,250 over the 5-year period of performance from September 2022 to August 2027. As the prime, Pacira Pharmaceuticals will deliver the contracted...